OptimizeRx Corporation
OPRX
$5.12
$0.224.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 107.35M | 109.43M | 109.51M | 104.75M | 94.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.35M | 109.43M | 109.51M | 104.75M | 94.37M |
| Cost of Revenue | 32.16M | 35.83M | 37.99M | 37.30M | 33.85M |
| Gross Profit | 75.18M | 73.60M | 71.52M | 67.45M | 60.52M |
| SG&A Expenses | 52.91M | 53.94M | 56.91M | 55.95M | 55.96M |
| Depreciation & Amortization | 4.30M | 4.33M | 4.34M | 4.36M | 4.36M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 92.77M | 97.36M | 102.49M | 100.86M | 97.41M |
| Operating Income | 14.57M | 12.07M | 7.01M | 3.89M | -3.05M |
| Income Before Tax | 9.59M | 6.96M | 1.70M | -9.29M | -16.10M |
| Income Tax Expenses | 2.75M | 1.83M | 1.66M | 577.00K | -692.00K |
| Earnings from Continuing Operations | 6.84 | 5.13 | 0.03 | -9.87 | -15.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.84M | 5.13M | 34.00K | -9.87M | -15.41M |
| EBIT | 14.57M | 12.07M | 7.01M | 3.89M | -3.05M |
| EBITDA | 18.96M | 16.49M | 11.43M | 8.31M | 1.37M |
| EPS Basic | 0.37 | 0.27 | 0.00 | -0.54 | -0.84 |
| Normalized Basic EPS | 0.33 | 0.24 | 0.07 | -0.05 | -0.29 |
| EPS Diluted | 0.34 | 0.25 | 0.00 | -0.54 | -0.84 |
| Normalized Diluted EPS | 0.32 | 0.23 | 0.06 | -0.05 | -0.29 |
| Average Basic Shares Outstanding | 74.51M | 74.22M | 73.98M | 73.72M | 73.47M |
| Average Diluted Shares Outstanding | 76.62M | 76.33M | 75.36M | 74.23M | 73.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |